Schedule 13D ownership disclosure

BIOMX INC

Common Stock, par value $0.0001 per share · CUSIP: 09090D509

Event date: 2026-02-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Deerfield Private Design Fund V, L.P.Reported CIK 0001815437

    Shares: 494,267.00 · Class: 9.99%

  • Deerfield Mgmt V, L.P.Reported CIK 0001876688

    Shares: 494,267.00 · Class: 9.99%

  • Deerfield Healthcare Innovations Fund II, L.P.Reported CIK 0001780064

    Shares: 494,267.00 · Class: 9.99%

  • Deerfield Mgmt HIF II, L.P.Reported CIK 0001665736

    Shares: 494,267.00 · Class: 9.99%

  • Deerfield Management Company, L.P.Reported CIK 0001009258

    Shares: 989,056.00 · Class: 9.99%

  • James E. FlynnReported CIK 0001352546

    Shares: 989,056.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193805-26-000123
Form type
SCHEDULE 13D/A
Filer
BiomX Inc.
CIK
CIK 1739174
Filed
Feb 11, 2026
Reporting period
Feb 09, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub